Technical Analysis for AGTC - Applied Genetic Technologies Corporation

Grade Last Price % Change Price Change
grade C 8.16 0.37% 0.03
AGTC closed up 0.37 percent on Friday, January 17, 2020, on 36 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical AGTC trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Calm After Storm Range Contraction 0.37%
Wide Bands Range Expansion 0.37%
Golden Cross Bullish -0.12%
Calm After Storm Range Contraction -0.12%
Wide Bands Range Expansion -0.12%
1,2,3 Pullback Bullish Bullish Swing Setup -2.16%
180 Bullish Setup Bullish Swing Setup -2.16%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.16%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops gene therapy products for inherited orphan ophthalmology diseases in the United States. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. The company also completed preclinical proof-of-concept studies, and Phase I and Phase II clinical trials of a treatment for alpha-1 antitrypsin deficiency, an inherited orphan lung disease. In addition, it has proof-of-concept programs for other eye diseases, such as leber congenital amaurosis (type 2), and wet form of age-related macular degeneration. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida.
Biotechnology Medical Specialties Diseases Gene Therapy Ophthalmology Age Related Macular Degeneration Vision Retinitis Pigmentosa Antitrypsin Deficiency Eye Diseases Gene Therapy Products Eye Disease Retinoschisis X Linked Retinitis Pigmentosa

Is AGTC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.5
52 Week Low 2.52
Average Volume 1,232,994
200-Day Moving Average 3.78
50-Day Moving Average 3.96
20-Day Moving Average 5.62
10-Day Moving Average 7.00
Average True Range 0.76
ADX 53.09
+DI 45.65
-DI 5.46
Chandelier Exit (Long, 3 ATRs ) 7.22
Chandelier Exit (Short, 3 ATRs ) 4.98
Upper Bollinger Band 9.54
Lower Bollinger Band 1.71
Percent B (%b) 0.82
BandWidth 139.20
MACD Line 1.31
MACD Signal Line 1.00
MACD Histogram 0.3085
Fundamentals Value
Market Cap 147.59 Million
Num Shares 18.1 Million
EPS 0.63
Price-to-Earnings (P/E) Ratio 12.95
Price-to-Sales 1.74
Price-to-Book 0.60
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.00
Resistance 3 (R3) 9.03 8.78 8.86
Resistance 2 (R2) 8.78 8.57 8.77 8.81
Resistance 1 (R1) 8.47 8.43 8.35 8.44 8.77
Pivot Point 8.22 8.22 8.16 8.21 8.22
Support 1 (S1) 7.91 8.01 7.79 7.88 7.55
Support 2 (S2) 7.66 7.87 7.65 7.51
Support 3 (S3) 7.35 7.66 7.46
Support 4 (S4) 7.32